Is Brensocatib Available in the USA? Understanding Its FDA Approval and Access
•
2 min read
On August 12, 2025, the U.S. Food and Drug Administration (FDA) approved Brensocatib, brand name Brinsupri, as the first-ever treatment for non-cystic fibrosis bronchiectasis (NCFB). This landmark decision means that yes, **is Brensocatib available in the USA**, offering a new targeted therapy option for patients aged 12 and older with this chronic lung disease.
